par Hardy, Jean-François;Bélisle, Sylvain;Van Der Linden, Philippe 
Référence Alternatives to Blood Transfusion in Transfusion Medicine: Second Edition, Wiley-Blackwell, page (278-292)
Publication Publié, 2010-09
Référence Alternatives to Blood Transfusion in Transfusion Medicine: Second Edition, Wiley-Blackwell, page (278-292)
Publication Publié, 2010-09
Partie d'ouvrage collectif
| Titre: |
|
| Auteur: | Hardy, Jean-François; Bélisle, Sylvain; Van Der Linden, Philippe |
| Informations sur la publication: | Alternatives to Blood Transfusion in Transfusion Medicine: Second Edition, Wiley-Blackwell, page (278-292) |
| Statut de publication: | Publié, 2010-09 |
| Sujet CREF: | Généralités |
| Mots-clés: | Adverse Event Reporting System (AERS) |
| Efficacy of rFVIIa for the prevention of excessive bleeding and the reduction of transfusions | |
| Efficacy of rFVIIa for the treatment of excessive bleeding and the reduction of transfusions | |
| Food and Drug Administration (FDA) | |
| Fresh frozen plasma (FFP) | |
| Intracerebral hemorrhage (ICH) | |
| Randomized controlled trial (RCT) | |
| Red blood cells (RBC) | |
| Safety of rFVIIa when used for the prevention or the treatment of excessive bleeding and the reduction of transfusions | |
| Note générale: | SCOPUS: ch.b |
| Langue: | Anglais |
| Identificateurs: | urn:isbn:9781405163217 |
| info:doi/10.1002/9781444319583.ch23 | |
| info:scp/84885554013 |
